Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: A comparison with aspirin and morpholinosydnonimine (SIN-1)

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 4, 2007, Pages 1033-1039

  Wan, Song ^a   Shukla, Nilima ^b   Angelini, Gianni D ^b   Yim, Anthony P C ^a   Johnson, Jason L ^b   Jeremy, Jamie Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; LINSIDOMINE; NITRIC OXIDE DONOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY SURGERY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG POTENCY; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SWINE;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANASTOMOSIS, SURGICAL; ANIMALS; ASPIRIN; CAROTID ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT OCCLUSION, VASCULAR; MALE; MOLSIDOMINE; NITRIC OXIDE DONORS; SAPHENOUS VEIN; STATISTICS, NONPARAMETRIC; SWINE; TUNICA INTIMA;

EID: 34548814152     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.06.017     Document Type: Article

References (29)

1. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition and prevention. Circulation 97 (1998) 16-31
2. Jeremy J.Y., Gadsdon P., Shukla N., Vijayan V., Wyatt M., Newby A.C., et al. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials 28 (2007) 895-908
3. The Society of Cardiothoracic Surgeons of Great Britain and Ireland National Adult Cardiac Surgical Database Report 2003 (2003), Dendrite Clinical Systems, Oxfordshire (UK)
4. Campeau L. Lipid lowering and coronary bypass graft surgery. Curr Opin Cardiol 15 (2000) 395-399
5. Goldman S., Copeland J., Moritz T., Henderson W., Zadina K., Ovitt T., et al. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation 89 (1994) 1138-1143
6. Jeremy J.Y., Mehta D., Bryan A.J., Lewis D., and Angelini G.D. Platelets and saphenous vein graft failure following coronary artery bypass graft surgery. Platelets 8 (1997) 295-309
7. Shukla N., Angelini G.D., Wan I., Talpahewa S.P., Ascione R., and Jeremy J.Y. Potential role of nitroaspirins in the treatment of vein graft failure. Ann Thorac Surg 75 (2003) 1437-1442
8. Jeremy J.Y., Mikhailidis D.P., and Dandona P. Effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal and platelet prostanoid synthesis. Br J Rheumatol 29 (1990) 116-119
9. Tsang V., Jeremy J.Y., Mikhailidis D.P., Walesby R.K., Wright J.V., and Dandona P. The release of prostacyclin by the human aorta. Cardiovasc Res 22 (1988) 489-493
10. Gum P.A., Kottke-Marchant K., Welsh P.A., White J., and Topol E.J. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41 (2003) 961-965
11. Jeremy J.Y., Rowe D., Emsley A.M., and Newby A.C. Nitric oxide and vascular smooth muscle cell proliferation. Cardiovasc Res 43 (1999) 658-665
12. Wallace J.L., Muscara M.N., de Nucci G., Zamuner S., Cirino G., del Soldato P., et al. Nitric oxide-releasing NSAIDs: GI-safe antithrombotics. Drugs 2 (1999) 321-326
13. Gresele P., and Momi S. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. Cardiovasc Drug Rev 24 (2006) 48-68
14. Napoli C., Cirino G., Del Soldato P., Sorrentino R., Sica V., Condorelli M., et al. Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolaemic mice. Proc Natl Acad Sci U S A 98 (2001) 2860-2864
15. B) receptor binding to different regions of porcine interposition venous-arterial grafts. Atherosclerosis 137 (1998) 233-242
16. Wan S., Yim A., Shukla N., Johnson J.L., Angelini G.D., and Jeremy J.Y. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein grafts. J Thorac Cardiovasc Surg 133 (2007) 494-500
17. A receptor antagonist BSF 302146 is a potent inhibitor of porcine vein graft thickening in vivo. J Thorac Cardiovasc Surg 27 (2004) 1317-1322
18. 2 production. Thromb Haemost 76 (1996) 791-798
19. Wallace J.L., McKnight W., Wilson T.L., del Soldato P., and Cirino G. Reduction of shock-induced gastric damage by nitric oxide-releasing aspirin derivative: role of neutrophils. Am J Physiol 273 (1997) G1246-G1251
20. Muscara M.N., Lovren F., McKnight W., Dicay M., del Soldato P., Triggle C.R., et al. Vasorelaxant effects of nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats. Br J Pharmacol 133 (2001) 1314-1322
21. Hirko M.K., McShannic J.R., Schmidt S.P., Sharp W.V., Evancho M.M., Sims R.L., et al. Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts. J Vasc Surg 17 (1993) 877-887
22. Dobrin P.B., Golan J., Fareed J., Blakeman B., and Littoy F.N. Pre- vs postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein grafts. J Cardiovasc Surg 33 (1992) 705-709
23. Landymore R.W., MacAulay M.A., and Manku M.S. The effects of low, medium and high dose aspirin on intimal proliferation in autologous vein grafts used for arterial reconstruction. Eur J Cardiothorac Surg 4 (1990) 441-444
24. Landymore R.W., MacAulay M.A., and Manku M.S. The effects of low, medium and high dose aspirin on intimal proliferation in autologous vein grafts used for arterial reconstruction. Eur J Cardiothorac Surg 4 (1990) 441-444
25. Frantz B., and O'Neill E.A. The effect of sodium salicylate and aspirin on NF-kappa B. Science 270 (1995) 2017-2019
26. Mehta D., George S.J., Jeremy J.Y., Izzat M.B., Southgate K.M., Bryan A.J., et al. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med 4 (1998) 235-239
27. Dobrin P.B. Mechanical forces associated with the development of intimal hyperplasia with respect to vascular grafts. In: Dobrin P.B. (Ed). Intimal hyperplasia (1994), RG Landes, Austin 85-109
28. Caro C., Jeremy J.Y., Watkins N., Bulbulia R., Angelini G.D., Smith F., et al. Geometry of unstented and stented pig common carotid artery bypass grafts. Biorheology 39 (2002) 507-512
29. phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation 110 (2004) 1140-1147